BOKA Sciences
Frank has served as the Managing General Partner of the Gideon Hixon Fund since 2004 and a General Partner since 1990. He is also a Managing Director of DFJ Frontier, a Draper Fisher Jurvetson affiliated venture capital fund with $80M under management focused on seed and early-stage technology companies on the west coast. Previously, he was the CEO and Executive Chairman of Prolacta Bioscience. Frank received his MBA from Harvard Business School and a BA cum laude from Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BOKA Sciences
Boka Sciences is a medical device company utilizing saliva to quickly and accurately diagnose patients suffering from diseases effecting salivary flow. The company is developing a portfolio of products based on its proprietary “Bokaflo” system. The first product will diagnose Xerostomia or dry-mouth, a condition affecting an estimated 60-70 million Americans.